182 related articles for article (PubMed ID: 18848347)
1. Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.
Smaldone MC; Vodovotz Y; Tyagi V; Barclay D; Philips BJ; Yoshimura N; Chancellor MB; Tyagi P
Urology; 2009 Feb; 73(2):421-6. PubMed ID: 18848347
[TBL] [Abstract][Full Text] [Related]
2. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis.
Malley SE; Vizzard MA
Physiol Genomics; 2002; 9(1):5-13. PubMed ID: 11948286
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.
Vera PL; Wang X; Meyer-Siegler KL
Exp Biol Med (Maywood); 2008 May; 233(5):620-6. PubMed ID: 18375833
[TBL] [Abstract][Full Text] [Related]
4. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
[TBL] [Abstract][Full Text] [Related]
5. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
[TBL] [Abstract][Full Text] [Related]
6. Urinary uroplakin expression in cyclophosphamide-induced rat cystitis model.
Park H; Kyung YS; Lee G
Hum Exp Toxicol; 2016 Jun; 35(6):613-22. PubMed ID: 26424769
[TBL] [Abstract][Full Text] [Related]
7. Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).
Saban MR; Simpson C; Davis C; Wallis G; Knowlton N; Frank MB; Centola M; Gallucci RM; Saban R
BMC Immunol; 2007 May; 8():6. PubMed ID: 17506885
[TBL] [Abstract][Full Text] [Related]
8. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
Sakura M; Masuda H; Matsuoka Y; Yokoyama M; Kawakami S; Kihara K
BJU Int; 2009 Jan; 103(2):264-9. PubMed ID: 18710439
[TBL] [Abstract][Full Text] [Related]
9. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats.
Masuda H; Chancellor MB; Kihara K; Yoshimura N
Urology; 2006 Feb; 67(2):435-9. PubMed ID: 16461118
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder.
Augé C; Chene G; Dubourdeau M; Desoubzdanne D; Corman B; Palea S; Lluel P; Vergnolle N; Coelho AM
Eur J Pharmacol; 2013 May; 707(1-3):32-40. PubMed ID: 23541724
[TBL] [Abstract][Full Text] [Related]
11. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
12. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
[TBL] [Abstract][Full Text] [Related]
13. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
14. Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.
Tyagi P; Tyagi V; Yoshimura N; Witteemer E; Barclay D; Loughran PA; Zamora R; Vodovotz Y
J Inflamm (Lond); 2009 Aug; 6():23. PubMed ID: 19691848
[TBL] [Abstract][Full Text] [Related]
15. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation.
Kiuchi H; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2009 May; 181(5):2339-48. PubMed ID: 19303104
[TBL] [Abstract][Full Text] [Related]
16. Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat.
Kobayashi M; Nomura M; Fujihara H; Suzuki H; Otsubo H; Nishii H; Fujimoto N; Matsumoto T; Ueta Y
Peptides; 2009 Dec; 30(12):2348-56. PubMed ID: 19666069
[TBL] [Abstract][Full Text] [Related]
17. The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.
Xiao H; Wang T; Gao B; Liu J; Li S; Ma J
Neurourol Urodyn; 2024 Mar; 43(3):754-766. PubMed ID: 38356381
[TBL] [Abstract][Full Text] [Related]
18. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
Juszczak K; Gil K; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
[TBL] [Abstract][Full Text] [Related]
19. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
20. Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model.
Funahashi Y; Yoshida M; Yamamoto T; Majima T; Takai S; Gotoh M
J Urol; 2014 Apr; 191(4):1147-52. PubMed ID: 24262494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
